The dual health and economic crisis resulting from COVID-19 has brought into sharp focus the importance of ethical business conduct. SMEs in the medical device and pharmaceutical sectors have been significantly impacted, during a time when they are being called upon for major action.

This week, the APEC affirmed its commitment to push for patient health and cross-border trade with the launch of the ‘Vision 2025 for the Business Ethics for APEC SMEs Initiative’, a new vision for the next five years to reinforce business ethics and integrity in health-related sectors.